Elanco 동물 건강 법인
MX ˙ BMV ˙ US28414H1032
SecurityMX:ELAN / Elanco Animal Health Incorporated
InstitutionInvesco Ltd.
Latest Disclosed Ownership8,141,172 shares
Latest Disclosed Value $ 194,818,245
Invesco Ltd. reports 70.00% increase in ownership of ELAN / Elanco Animal Health Incorporated

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 8,141,172 shares of Elanco Animal Health Incorporated (MX:ELAN) valued at $194,818,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 4,789,037 shares of Elanco Animal Health Incorporated. This represents a change in shares of 70.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 8,141,172 3,352,135 70.00 194,818 79.76 0.0298
2026-02-19 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 4,789,037 3,690,735 336.04 108,376 389.96 0.0166
2025-11-13 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,098,302 528,572 92.78 22,120 171.90 0.0035
2025-08-13 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 569,730 14,468 2.61 8,136 39.54 0.0014
2025-05-12 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 555,262 18,871 3.52 5,830 -10.24 0.0011
2025-02-13 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 536,391 51,233 10.56 6,496 -8.85 0.0012
2024-11-12 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 485,158 -185,752 -27.69 7,127 -26.39 0.0014
2024-08-13 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 670,910 -1,000,174 -59.85 9,681 -64.41 0.0020
2024-05-14 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,671,084 882,770 111.98 27,205 131.63 0.0058
2024-02-13 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 788,314 280,288 55.17 11,746 105.69 0.0028
2023-11-13 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 508,026 44,447 9.59 5,710 22.45 0.0015
2023-08-11 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 463,579 -43,313 -8.54 4,664 -2.12 0.0012
2023-05-12 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 506,892 104,682 26.03 4,765 -3.07 0.0013
2023-02-13 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 402,210 4,503 1.13 4,915 -0.43 0.0014
2022-11-14 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 397,707 -7,094 -1.75 4,936 -37.88 0.0016
2022-08-15 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 404,801 11,806 3.00 7,946 -22.51 0.0024
2022-05-16 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 392,995 44,383 12.73 10,254 3.65 0.0026
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 348,612 -2,495 -0.71 9,893 -11.65 0.0024
2021-11-15 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 351,107 24,318 7.44 11,197 -1.23 0.0028
2021-08-17 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 326,789 37,311 12.89 11,337 32.99 0.0028
2021-05-17 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 289,478 50,240 21.00 8,525 16.19 0.0023
2021-02-16 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 239,238 -420,077 -63.71 7,337 -60.16 0.0021
2020-11-16 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 659,315 -1,381,329 -67.69 18,415 -57.93 0.0062
2020-08-14 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 2,040,644 -8,420,773 -80.49 43,771 -81.31 0.0157
2020-05-15 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 10,461,417 -3,737,285 -26.32 234,231 -43.98 0.0986
2020-02-14 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 14,198,702 988,893 7.49 418,152 19.05 0.1298
2019-11-14 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 13,209,809 2,137,638 19.31 351,250 -6.14 0.0919
2019-08-14 2019-06-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 11,072,171 9,697,267 705.31 374,240 748.75 0.0963
2019-08-14 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 11,072,171 -1,362,921 374,240
2019-05-15 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,374,904 307,076 28.76 44,093 30.96 0.0149
2019-02-14 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,067,828 67,828 6.78 33,669 -3.50 0.0129
2018-11-14 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,000,000 1,000,000 34,890 0.0110
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.